| Dataset Name | SOTA Method | Metric | Trend | ||
|---|---|---|---|---|---|
| N00694382 (set2) | SCARF | AUROC77.6 | 12 | 4d ago | |
| N00694382 (set1) | TransTab | AUROC74.7 | 12 | 4d ago | |
| N00079274 (ser2) | TransTab | AUROC71.1 | 12 | 4d ago | |
| N00079274 (ser1) | FT-Trans | AUROC69.2 | 12 | 4d ago | |
| N00312208 (set2) | TransTab | AUROC75.6 | 12 | 4d ago | |
| N00312208 (set1) | TransTab | AUROC0.73 | 12 | 4d ago | |
| N00174655 (set2) | XGBoost | AUROC88.6 | 12 | 4d ago | |
| N00174655 (set1) | TransTab | AUROC90.4 | 12 | 4d ago | |
| N00041119 (set2) | SCARF | AUROC65.7 | 12 | 4d ago | |
| N00041119 (set1) | TransTab | AUROC0.653 | 12 | 4d ago | |
| Clinical Trial Outcomes PharmaProjects | R2E-AUDIT | AUROC0.638 | 9 | 4d ago | |
| ClinicalTrials.gov (Phase 1, 2, 3) | ROC-AUC (Phase 2)0.88 | 7 | 4d ago | ||
| Clinical Trials (Phase 2) | ROC AUC0.88 | 6 | 4d ago | ||
| CTOD (Phase III) | MMCTOP | PR91.15 | 5 | 4d ago | |
| CTOD (Phase II) | MMCTOP | PR Score85.57 | 5 | 4d ago | |
| CTOD (Phase I) | MMCTOP | PR Score91.58 | 5 | 4d ago | |
| TOP (Phase III) | MMCTOP | Precision77.75 | 5 | 4d ago | |
| TOP (Phase II) | MMCTOP | PR Score68.22 | 5 | 4d ago | |
| TOP (Phase I) | MMCTOP | Precision86.88 | 5 | 4d ago | |
| Clinical Trials various (Phase 3) | ROC AUC0.81 | 1 | 4d ago |
